logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Reverse Transcriptase Inhibitors in HIV/AIDS Therapy by Gail Skowron, Richard Ogden ISBN 9781588296498, 9781597450850, 1588296490, 1597450855

  • SKU: EBN-1368648
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) Reverse Transcriptase Inhibitors in HIV/AIDS Therapy after payment.
Authors:Gail Skowron, Richard Ogden
Pages:543 pages.
Year:2006
Editon:1
Publisher:Humana Press
Language:english
File Size:6.38 MB
Format:pdf
ISBNS:9781588296498, 9781597450850, 1588296490, 1597450855
Categories: Ebooks

Product desciption

(Ebook) Reverse Transcriptase Inhibitors in HIV/AIDS Therapy by Gail Skowron, Richard Ogden ISBN 9781588296498, 9781597450850, 1588296490, 1597450855

A magisterial survey of all aspects of the reverse transcriptase inhibitors (RTIs) used to treat HIV/AIDS, including drug discovery, pharmacology, development of drug resistance, toxicity, and prevention of mother-to-child transmission of HIV/AIDS. The authors synthesize our current understanding of the role of reverse transcriptase in the viral life cycle, describe the discovery and development of eight nucleoside and nucleotide analogs that represent milestones in treatment history, and thoroughly discuss the question of toxicity and resistance to this class of drugs. They also address three non-nucleoside RTIs and their pharmacokinetics and comparative clinical efficacy, new RTIs currently under development, and the impact of approved agents on treatment, in general, and on vertical transmission in the developing world.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products